Clinical Trials on Marijuana Usage in Taiwan
Total 1 results
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Enrolling by invitationLower Urinary Tract Symptoms | Bladder Cancer | Intravenous Drug Usage | Herbal InteractionTaiwan
Sponsors and Collaborators
- Manmohan Cardiothoracic Vascular and Transplant Center
- IRCCS Don Gnocchi, Milano, Italy
- Walgreens Co.
- Pharmaspecific
- Edanz Group Japan Ltd
- Korrus Inc.
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- King Baudouin Foundation
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- Center for Rare Neurological Diseases, Norcross, GA
- Fundación Pública Andaluza Progreso y Salud
- Army Hospital, Percy
- Michael J. Wesley, PhD
- HeartPoint Global
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Laboratorios Viñas, S.A.
- Ana Paula Costella
- Frankel, Amylynne, M.D.
- Gulsah Ilhan
- Ruba Musharbash Nutrition Consultancy Center
- View Full List
Medical Conditions
- Pelvis Tumors
- Gastroenteritis Rotavirus
- Localized Unresectable Adult Primary Liver Cancer
- Paralysis of Vocal Cords or Larynx
- Menopause
- Cardiovascular Outcomes
- Cognitive Function, Social 1
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Kidney Damage
- Brain Arteriovenous Malformation
- Coagulation Disorder Neonatal
- Developmental Language Disorder and Language Impairment
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Lung Neuroendocrine Tumor
- Malignant Intracranial Germ Cell Tumor
- Uncontrolled Type 2 Diabetes Mellitus
- Impairment, Coordination
- Severe Atopic Dermatitis
- Ankylosed Teeth
- Facial Involvement
- View Full List
Drug Interventions
- Apremilast
- LDEPA
- Miglustat
- Ozanimod
- 5-Fluorouracil
- Dexmedetomidine
- Lidocaine/ ketamine
- Insulin
- Interferon beta-1b (Betaferon, BAY86-5046)
- Thiotepa
- Methotrexate
- Exendin 9-39
- Transdermal estradiol
- Interleukin-2
- Rituximab plus CHOP
- Extended release guanfacine
- FHND5071
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- CD25 treatment
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Estonia
- Contract Research Organizations in Finland
- Contract Research Organizations in Georgia
- Contract Research Organizations in India
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Russia
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Uruguay
- CRO list by country